Literature DB >> 10343345

Immune response during disease and recovery in the elderly.

B Lesourd1.   

Abstract

The present article reviews immune ageing and its relationship with nutritional ageing, with a particular insight into the influences of disease on both ageing processes. Immune ageing can be described primarily as the progressive appearance of immune dysregulations, mainly acquired immunity (mature: immature, naive: memory T lymphocyte subset decreases) leading to gradual increases in T-helper 2: T-helper 1 cells. This change is due initially to decreased thymic function, and later to accumulative antigen pressure over the lifespan. In contrast, innate immunity (macrophage functions) is preserved during the ageing process and in the elderly this leads to macrophage-lymphocyte dysequilibrium, which is particularly critical during on-going disease. Indeed, any disease induces long-lasting acute-phase reactions in aged patients and leads to body nutritional reserve (mainly protein) losses. Episodes of disease in the aged patient progressively deplete body nutritional reserves and lead to protein-energy malnutrition, undernutrition-associated immunodeficiency, and finally cachexia. Undernutrition is a common symptom in the elderly; protein-energy malnutrition is found in more than 50% of hospitalized elderly patients and in most elderly diseased subjects. In addition, micronutrient deficit or low levels are common in home-living self-sufficient apparently-healthy elderly subjects. All these nutritional deficits induce decreased immune responses, and micronutrient deficits are now thought to be partly responsible for the decreased immune responses (immune ageing?) observed in the apparently-healthy elderly. Indeed, several studies have shown that micronutrient supplements induce increased immune responses in the healthy elderly. The progression of infectious diseases depends on immune responses and on nutritional status before the onset of illness in aged subjects. In addition, recovery depends on the intensity of acute-phase responses in the undernourished elderly. In fact, chronic acute-phase responses, commonly associated with diseases in aged patients, lead to progressive lowering of metabolic responses in the undernourished elderly. This can be quantified by increased production of free radicals during treatment and these increases may explain the difficulty in successfully treating aged patients. Nutritive therapy in order to improve metabolic processes and also to maintain body reserves should be considered as a necessary adjuvant therapy in the treatment of elderly patients.

Entities:  

Mesh:

Year:  1999        PMID: 10343345     DOI: 10.1079/pns19990013

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  6 in total

Review 1.  Dysregulation of T-cell function in the elderly : scientific basis and clinical implications.

Authors:  Tamas Fulop; Anis Larbi; Anders Wikby; Eugenio Mocchegiani; Katsuiku Hirokawa; Graham Pawelec
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Effect of multivitamin and multimineral supplements on morbidity from infections in older people (MAVIS trial): pragmatic, randomised, double blind, placebo controlled trial.

Authors:  Alison Avenell; Marion K Campbell; Jonathan A Cook; Philip C Hannaford; Mary M Kilonzo; Geraldine McNeill; Anne C Milne; Craig R Ramsay; D Gwyn Seymour; Audrey I Stephen; Luke D Vale
Journal:  BMJ       Date:  2005-08-06

Review 3.  Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3.

Authors:  Laurence S Harbige
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

Review 4.  Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment.

Authors:  Jamie C DeWitt; Dori R Germolec; Robert W Luebke; Victor J Johnson
Journal:  Curr Protoc Toxicol       Date:  2016-02-01

Review 5.  Immunosupportive therapies in aging.

Authors:  Tamas Fülöp; Anis Larbi; Katsuiku Hirokawa; Eugenio Mocchegiani; Bruno Lesourds; Stephen Castle; Anders Wikby; Claudio Franceschi; Graham Pawelec
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

6.  Associating changes in the immune system with clinical diseases for interpretation in risk assessment.

Authors:  Michael I Luster; Dori R Germolec; Christine G Parks; Laura Blaciforti; Michael Kashon; Robert Luebke
Journal:  Curr Protoc Toxicol       Date:  2004
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.